Clovis Oncology Inc (NASDAQ:CLVS)

6.01
Delayed Data
As of Feb 26
 +0.07 / +1.18%
Today’s Change
3.62
Today|||52-Week Range
11.10
+25.21%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 5.88, with a high estimate of 13.00 and a low estimate of 3.00. The median estimate represents a -2.25% decrease from the last price of 6.01.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since January, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.68
Sales
$44.1M
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 33.14%
 
 
 
 
 
 
Growthannually 39.92%
 
 
 
 
 
 

Sales

Growthquarterly 1.74%
 
 
 
 
 
 
Growthannually 20.79%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.